Iridex Corporation reported financial results for the third quarter ended October 3, 2026, revealing a decline in total revenue but an increase in gross margins. Total revenue for the quarter was $10.2 million, representing a 19% decrease compared to the $12.5 million generated in the prior year period. The company attributed this drop to weaker customer demand in Europe and Asia, as well as order delays caused by distributors working through inventory and regulatory challenges.

Revenue was broken down by product family. The Cyclo G6 product family generated $3.2 million, down from $3.5 million in the prior year. This decrease was driven by lower international probe orders, partially offset by higher average selling prices in the U.S. Retina product revenue was $5.1 million, a decrease from $6.7 million, primarily due to international market headwinds. Other revenue, which includes service and royalties, was $1.9 million compared to $2.2 million in the prior year.

Despite the revenue decline, gross margin improved significantly. Gross margin for the third quarter of 2026 was 42.4%, compared to 32.1% in the prior year period. The company noted that this improvement reflects a one-time write-off recorded in the third quarter of 2025 and more favorable geographic mix and pricing discipline. Excluding the impact of the 2025 write-off, pro forma gross margin improved by 370 basis points. Operating expenses remained flat at $5.5 million compared to $5.4 million in the prior year. As a result, the company reported a net loss of $1.4 million, or $0.08 per share, compared to a net loss of $1.6 million, or $0.09 per share, in the same period of 2025.

Management highlighted ongoing cost savings initiatives, including the recent relocation of the company's headquarters to San Jose, which is expected to deliver approximately $600,000 in annualized savings. The company also noted that cash utilization during the quarter was only $1 million and is expected to decrease significantly in the fourth quarter. Looking ahead, Iridex is reducing its annual revenue guidance for fiscal year 2026 to between $46 million and $48 million, down from the previous range of $51 million to $53 million. The company continues to expect fiscal year 2026 adjusted operating expenses to be in the range of $19 million to $19.5 million.